Anti-arrhythmic Medication v. MRI-Merge Ablation in the Treatment of Ventricular Tachycardia

You may be eligible if

• Inclusion:
• Current treatment with amiodarone
• Ischemic or non-ischemic cardiomyopathy
• Monomorphic ventricular tachycardia at any cycle length, with \> 1 occurrence of the same cycle length and morphology, at least one episode needs to be of sufficient duration to result in a shock.
• No contraindication to up titration of meds or to VT radiofrequency ablation (RFA)
• Exclusion:
• Primary antiarrhythmic medication other than amiodarone
• Amiodarone at dose of 600 mg daily or higher
• Polymorphic VT as culprit rhythm
• History of metal exposure (welding)
• Pregnant women
• Recent myocardial infarction
• Planned coronary revascularization
• Implantable cardiac devices not previously tested for safety in the setting of MRI
• Glomerular Filtration Rate (GFR) \< 30 ml/min